IDEOlogy Health, a provider of non-promotional, multi-channel medical education to oncology professionals, on Tuesday announced two exclusive strategic partnership agreements with West Cancer Center & Research Institute, designed to elevate physician and Advanced Practice Provider (APP) education.
Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community.
West Cancer Center & Research Institute offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care.
By combining IDEOlogy Health's innovative educational platforms with West's clinical expertise, the collaboration aims to help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care.
Racura Oncology identifies mechanism of action for (E,E)-bisantrene
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline
NextCell Pharma and FUJIFILM Biosciences launch global MSC research product
ZYUS Life Sciences receives second US pain management patent
MingMed Biotechnology presents QA102 Phase II trial data in intermediate AMD at ARVO 2026
Vanda Pharmaceuticals NEREUS (tradipitant) commercially available for Motion sickness in US
Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia
Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review
Bambusa Therapeutics completes patient enrolment in Phase 1b/2a trial for atopic dermatitis
Lab Thread launches unified digital platform for biological research workflows
Curocell secures full approval for RIMQARTO to enter CAR-T therapy market